A detailed history of Jpmorgan Chase & CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Jpmorgan Chase & CO holds 88,814,123 shares of BMY stock, worth $3.91 Billion. This represents 0.44% of its overall portfolio holdings.

Number of Shares
88,814,123
Previous 90,048,274 1.37%
Holding current value
$3.91 Billion
Previous $4.62 Billion 4.24%
% of portfolio
0.44%
Previous 0.48%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$47.98 - $54.4 $59.2 Million - $67.1 Million
-1,234,151 Reduced 1.37%
88,814,123 $4.82 Billion
Q4 2023

Feb 12, 2024

SELL
$48.48 - $57.85 $324 Million - $387 Million
-6,692,109 Reduced 6.92%
90,048,274 $4.62 Billion
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $381 Million - $425 Million
-6,573,182 Reduced 6.36%
96,740,383 $5.61 Billion
Q2 2023

Aug 11, 2023

BUY
$63.71 - $70.74 $427 Million - $474 Million
6,699,923 Added 6.93%
103,313,565 $6.61 Billion
Q1 2023

May 18, 2023

BUY
$65.71 - $74.53 $65.8 Million - $74.6 Million
1,000,670 Added 1.05%
96,613,642 $6.7 Billion
Q1 2023

May 11, 2023

SELL
$65.71 - $74.53 $200 Million - $227 Million
-3,050,504 Reduced 3.09%
95,612,972 $6.63 Billion
Q4 2022

Feb 13, 2023

SELL
$68.48 - $81.09 $57.2 Million - $67.7 Million
-834,677 Reduced 0.84%
98,663,476 $7.1 Billion
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $225,926 - $134 Million
1,737,893 Added 1.78%
99,498,153 $7.07 Billion
Q2 2022

Aug 11, 2022

BUY
$72.62 - $79.98 $281 Million - $310 Million
3,876,301 Added 4.13%
97,760,260 $7.53 Billion
Q1 2022

May 11, 2022

BUY
$61.48 - $73.72 $131 Million - $157 Million
2,133,783 Added 2.33%
93,883,959 $6.86 Billion
Q4 2021

Feb 10, 2022

BUY
$53.63 - $62.52 $331 Million - $386 Million
6,172,949 Added 7.21%
91,750,176 $5.72 Billion
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $5.06 Billion - $5.93 Billion
85,577,227 New
85,577,227 $5.06 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $93.6B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.